RESULTS FOR : 'Regulatory'
Showing 1 to 3 of 3 results |    
Keyword Search
Show#
Show#
Results Category/Section
Phenotypic Screening - Advancing the science from discovery to regulatory science

Phenotypic screening is transforming drug discovery as advances are made in development of human-based physiologically-relevant in vitro systems.

Therapeutic Drug Repurposing, Repositioning and Rescue Part III: Market exclusivity using Intellectual Property and regulatory pathways

There is a growing consensus that Drug Repurposing, Repositioning and Rescue (DRPx) can impact the prescription drug industry for all concerned stakeholders. In part this is due to the fact that the pharmaceutical industry now accrues ~25% of its annual revenues from DRPx products.

Personalised Medicine Market and Regulatory Landscape

Over the past several years, there has been continuing interest in the deployment of personalised medicine via the development of companion diagnostics/therapeutics.